TSX-V:ZYUS • CA9899601095
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZYUS LIFE SCIENCES CORP (ZYUS.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-12 | STIFEL CANADA | Maintains | Buy -> Buy |
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 351K | 481K 37.04% | 452.48K -5.93% | ||
| EBITDA YoY % growth | N/A | -14.086M | -11.739M 16.66% | -11.11K 99.91% | |
| EBIT YoY % growth | -460K -100.00% | -17.192M -3,637.39% | -14.7M 14.50% | -12.524M 14.80% | |
| Operating Margin | N/A | -4,898.01% | -3,056.13% | -2,767.86% | |
| EPS YoY % growth | N/A | N/A | -0.47 -2.27% | -0.22 52.72% |
All data in CAD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.05 83.17% |
| Revenue Q2Q % growth | 110.09K -12.63% |
| EBITDA Q2Q % growth | -3.03K 98.75% |
| EBIT Q2Q % growth | -3.232M -0.91% |
All data in CAD
5 analysts have analysed ZYUS.CA and the average price target is 1.53 CAD. This implies a price increase of 178.18% is expected in the next year compared to the current price of 0.55.
The consensus EPS estimate for the next earnings of ZYUS LIFE SCIENCES CORP (ZYUS.CA) is -0.05 CAD and the consensus revenue estimate is 110.09K CAD.
The number of analysts covering ZYUS LIFE SCIENCES CORP (ZYUS.CA) is 5.